▶ 調査レポート

世界の経口固形製剤受託製造市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Oral Solid Dosage Contract Manufacturing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の経口固形製剤受託製造市場 2021:企業別、地域別、種類・用途別 / Global Oral Solid Dosage Contract Manufacturing Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-2104Z10303資料のイメージです。• レポートコード:GIR-2104Z10303
• 出版社/出版日:GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、127ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、経口固形製剤受託製造のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口固形製剤受託製造の種類別市場規模(錠剤、カプセル、粉末&顆粒、その他)、用途別市場規模(特殊/中量、ジェネリック、Big Pharma、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・経口固形製剤受託製造の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Catalent、DPx、Lonza Group (Capsugel)、Piramal Pharma Solutions、Aenova、Jubilant、Famar、Boehringer Ingelheim、Fareva Holding、AbbVie Contract Manufacturing、Nipro Pharma、Sopharma、Mylan (DPT Laboratories)、Recipharm、NextPharma、Dishman、Aesica Pharmaceuticals、CordenPharma
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:錠剤、カプセル、粉末&顆粒、その他
・用途別分析2016年-2026年:特殊/中量、ジェネリック、Big Pharma、その他
・経口固形製剤受託製造の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・経口固形製剤受託製造のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・経口固形製剤受託製造のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・経口固形製剤受託製造の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・経口固形製剤受託製造の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Oral Solid Dosage Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oral Solid Dosage Contract Manufacturing size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Oral Solid Dosage Contract Manufacturing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Oral Solid Dosage Contract Manufacturing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Tablets
Capsules
Powders & Granules
Others

Market segment by Application, can be divided into
Specialty/Midsize
Generics
Big Pharma
Other

Market segment by players, this report covers
Catalent
DPx
Lonza Group (Capsugel)
Piramal Pharma Solutions
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie Contract Manufacturing
Nipro Pharma
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma
Dishman
Aesica Pharmaceuticals
CordenPharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Oral Solid Dosage Contract Manufacturing
1.2 Classification of Oral Solid Dosage Contract Manufacturing by Type
1.2.1 Overview: Global Oral Solid Dosage Contract Manufacturing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Type in 2020
1.2.3 Tablets
1.2.4 Capsules
1.2.5 Powders & Granules
1.2.6 Others
1.3 Global Oral Solid Dosage Contract Manufacturing Market by Application
1.3.1 Overview: Global Oral Solid Dosage Contract Manufacturing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Specialty/Midsize
1.3.3 Generics
1.3.4 Big Pharma
1.3.5 Other
1.4 Global Oral Solid Dosage Contract Manufacturing Market Size & Forecast
1.5 Global Oral Solid Dosage Contract Manufacturing Market Size and Forecast by Region
1.5.1 Global Oral Solid Dosage Contract Manufacturing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Oral Solid Dosage Contract Manufacturing Market Size by Region, (2016-2021)
1.5.3 North America Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2016-2026)
1.5.4 Europe Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2016-2026)
1.5.6 South America Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Oral Solid Dosage Contract Manufacturing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Solid Dosage Contract Manufacturing Market Drivers
1.6.2 Oral Solid Dosage Contract Manufacturing Market Restraints
1.6.3 Oral Solid Dosage Contract Manufacturing Trends Analysis
2 Company Profiles
2.1 Catalent
2.1.1 Catalent Details
2.1.2 Catalent Major Business
2.1.3 Catalent Oral Solid Dosage Contract Manufacturing Product and Solutions
2.1.4 Catalent Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Catalent Recent Developments and Future Plans
2.2 DPx
2.2.1 DPx Details
2.2.2 DPx Major Business
2.2.3 DPx Oral Solid Dosage Contract Manufacturing Product and Solutions
2.2.4 DPx Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 DPx Recent Developments and Future Plans
2.3 Lonza Group (Capsugel)
2.3.1 Lonza Group (Capsugel) Details
2.3.2 Lonza Group (Capsugel) Major Business
2.3.3 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Product and Solutions
2.3.4 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Lonza Group (Capsugel) Recent Developments and Future Plans
2.4 Piramal Pharma Solutions
2.4.1 Piramal Pharma Solutions Details
2.4.2 Piramal Pharma Solutions Major Business
2.4.3 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Product and Solutions
2.4.4 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.5 Aenova
2.5.1 Aenova Details
2.5.2 Aenova Major Business
2.5.3 Aenova Oral Solid Dosage Contract Manufacturing Product and Solutions
2.5.4 Aenova Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Aenova Recent Developments and Future Plans
2.6 Jubilant
2.6.1 Jubilant Details
2.6.2 Jubilant Major Business
2.6.3 Jubilant Oral Solid Dosage Contract Manufacturing Product and Solutions
2.6.4 Jubilant Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Jubilant Recent Developments and Future Plans
2.7 Famar
2.7.1 Famar Details
2.7.2 Famar Major Business
2.7.3 Famar Oral Solid Dosage Contract Manufacturing Product and Solutions
2.7.4 Famar Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Famar Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Product and Solutions
2.8.4 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
2.9 Fareva Holding
2.9.1 Fareva Holding Details
2.9.2 Fareva Holding Major Business
2.9.3 Fareva Holding Oral Solid Dosage Contract Manufacturing Product and Solutions
2.9.4 Fareva Holding Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Fareva Holding Recent Developments and Future Plans
2.10 AbbVie Contract Manufacturing
2.10.1 AbbVie Contract Manufacturing Details
2.10.2 AbbVie Contract Manufacturing Major Business
2.10.3 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Product and Solutions
2.10.4 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 AbbVie Contract Manufacturing Recent Developments and Future Plans
2.11 Nipro Pharma
2.11.1 Nipro Pharma Details
2.11.2 Nipro Pharma Major Business
2.11.3 Nipro Pharma Oral Solid Dosage Contract Manufacturing Product and Solutions
2.11.4 Nipro Pharma Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Nipro Pharma Recent Developments and Future Plans
2.12 Sopharma
2.12.1 Sopharma Details
2.12.2 Sopharma Major Business
2.12.3 Sopharma Oral Solid Dosage Contract Manufacturing Product and Solutions
2.12.4 Sopharma Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Sopharma Recent Developments and Future Plans
2.13 Mylan (DPT Laboratories)
2.13.1 Mylan (DPT Laboratories) Details
2.13.2 Mylan (DPT Laboratories) Major Business
2.13.3 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Product and Solutions
2.13.4 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Mylan (DPT Laboratories) Recent Developments and Future Plans
2.14 Recipharm
2.14.1 Recipharm Details
2.14.2 Recipharm Major Business
2.14.3 Recipharm Oral Solid Dosage Contract Manufacturing Product and Solutions
2.14.4 Recipharm Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Recipharm Recent Developments and Future Plans
2.15 NextPharma
2.15.1 NextPharma Details
2.15.2 NextPharma Major Business
2.15.3 NextPharma Oral Solid Dosage Contract Manufacturing Product and Solutions
2.15.4 NextPharma Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 NextPharma Recent Developments and Future Plans
2.16 Dishman
2.16.1 Dishman Details
2.16.2 Dishman Major Business
2.16.3 Dishman Oral Solid Dosage Contract Manufacturing Product and Solutions
2.16.4 Dishman Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Dishman Recent Developments and Future Plans
2.17 Aesica Pharmaceuticals
2.17.1 Aesica Pharmaceuticals Details
2.17.2 Aesica Pharmaceuticals Major Business
2.17.3 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Product and Solutions
2.17.4 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Aesica Pharmaceuticals Recent Developments and Future Plans
2.18 CordenPharma
2.18.1 CordenPharma Details
2.18.2 CordenPharma Major Business
2.18.3 CordenPharma Oral Solid Dosage Contract Manufacturing Product and Solutions
2.18.4 CordenPharma Oral Solid Dosage Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 CordenPharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oral Solid Dosage Contract Manufacturing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Oral Solid Dosage Contract Manufacturing Players Market Share
3.2.2 Top 10 Oral Solid Dosage Contract Manufacturing Players Market Share
3.2.3 Market Competition Trend
3.3 Oral Solid Dosage Contract Manufacturing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Oral Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2016-2021)
4.2 Global Oral Solid Dosage Contract Manufacturing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Application (2016-2021)
5.2 Oral Solid Dosage Contract Manufacturing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2026)
6.2 North America Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2026)
6.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Country
6.3.1 North America Oral Solid Dosage Contract Manufacturing Revenue by Country (2016-2026)
6.3.2 United States Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
6.3.3 Canada Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
6.3.4 Mexico Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2026)
7.2 Europe Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2026)
7.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country
7.3.1 Europe Oral Solid Dosage Contract Manufacturing Revenue by Country (2016-2026)
7.3.2 Germany Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
7.3.3 France Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
7.3.5 Russia Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
7.3.6 Italy Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2026)
8.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2026)
8.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Region (2016-2026)
8.3.2 China Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.3 Japan Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.4 South Korea Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.5 India Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.7 Australia Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2026)
9.2 South America Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2026)
9.3 South America Oral Solid Dosage Contract Manufacturing Market Size by Country
9.3.1 South America Oral Solid Dosage Contract Manufacturing Revenue by Country (2016-2026)
9.3.2 Brazil Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
9.3.3 Argentina Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2026)
10.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2026)
10.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Country (2016-2026)
10.3.2 Turkey Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
10.3.4 UAE Oral Solid Dosage Contract Manufacturing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Oral Solid Dosage Contract Manufacturing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Oral Solid Dosage Contract Manufacturing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Oral Solid Dosage Contract Manufacturing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Oral Solid Dosage Contract Manufacturing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Region (2021-2026)
Table 6. Catalent Corporate Information, Head Office, and Major Competitors
Table 7. Catalent Major Business
Table 8. Catalent Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 9. Catalent Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. DPx Corporate Information, Head Office, and Major Competitors
Table 11. DPx Major Business
Table 12. DPx Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 13. DPx Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Lonza Group (Capsugel) Corporate Information, Head Office, and Major Competitors
Table 15. Lonza Group (Capsugel) Major Business
Table 16. Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 17. Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Piramal Pharma Solutions Corporate Information, Head Office, and Major Competitors
Table 19. Piramal Pharma Solutions Major Business
Table 20. Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 21. Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Aenova Corporate Information, Head Office, and Major Competitors
Table 23. Aenova Major Business
Table 24. Aenova Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 25. Aenova Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Jubilant Corporate Information, Head Office, and Major Competitors
Table 27. Jubilant Major Business
Table 28. Jubilant Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 29. Jubilant Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Famar Corporate Information, Head Office, and Major Competitors
Table 31. Famar Major Business
Table 32. Famar Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 33. Famar Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 35. Boehringer Ingelheim Major Business
Table 36. Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 37. Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Fareva Holding Corporate Information, Head Office, and Major Competitors
Table 39. Fareva Holding Major Business
Table 40. Fareva Holding Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 41. Fareva Holding Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. AbbVie Contract Manufacturing Corporate Information, Head Office, and Major Competitors
Table 43. AbbVie Contract Manufacturing Major Business
Table 44. AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 45. AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Nipro Pharma Corporate Information, Head Office, and Major Competitors
Table 47. Nipro Pharma Major Business
Table 48. Nipro Pharma Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 49. Nipro Pharma Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Sopharma Corporate Information, Head Office, and Major Competitors
Table 51. Sopharma Major Business
Table 52. Sopharma Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 53. Sopharma Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Mylan (DPT Laboratories) Corporate Information, Head Office, and Major Competitors
Table 55. Mylan (DPT Laboratories) Major Business
Table 56. Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 57. Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Recipharm Corporate Information, Head Office, and Major Competitors
Table 59. Recipharm Major Business
Table 60. Recipharm Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 61. Recipharm Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. NextPharma Corporate Information, Head Office, and Major Competitors
Table 63. NextPharma Major Business
Table 64. NextPharma Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 65. NextPharma Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Dishman Corporate Information, Head Office, and Major Competitors
Table 67. Dishman Major Business
Table 68. Dishman Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 69. Dishman Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Aesica Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 71. Aesica Pharmaceuticals Major Business
Table 72. Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 73. Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. CordenPharma Corporate Information, Head Office, and Major Competitors
Table 75. CordenPharma Major Business
Table 76. CordenPharma Oral Solid Dosage Contract Manufacturing Product and Solutions
Table 77. CordenPharma Oral Solid Dosage Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Global Oral Solid Dosage Contract Manufacturing Revenue (USD Million) by Players (2019-2021)
Table 79. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Players (2019-2021)
Table 80. Breakdown of Oral Solid Dosage Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Oral Solid Dosage Contract Manufacturing Players Head Office, Products and Services Provided
Table 82. Oral Solid Dosage Contract Manufacturing Mergers & Acquisitions in the Past Five Years
Table 83. Oral Solid Dosage Contract Manufacturing New Entrants and Expansion Plans
Table 84. Global Oral Solid Dosage Contract Manufacturing Revenue (USD Million) by Type (2016-2021)
Table 85. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Type (2016-2021)
Table 86. Global Oral Solid Dosage Contract Manufacturing Revenue Forecast by Type (2021-2026)
Table 87. Global Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2021)
Table 88. Global Oral Solid Dosage Contract Manufacturing Revenue Forecast by Application (2021-2026)
Table 89. North America Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 90. North America Oral Solid Dosage Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 91. North America Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 92. North America Oral Solid Dosage Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 93. North America Oral Solid Dosage Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)
Table 94. North America Oral Solid Dosage Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)
Table 95. Europe Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 96. Europe Oral Solid Dosage Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 97. Europe Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 98. Europe Oral Solid Dosage Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 99. Europe Oral Solid Dosage Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)
Table 100. Europe Oral Solid Dosage Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)
Table 101. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 102. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 104. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Region (2016-2021) & (USD Million)
Table 106. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue by Region (2021-2026) & (USD Million)
Table 107. South America Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 108. South America Oral Solid Dosage Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 109. South America Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 110. South America Oral Solid Dosage Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 111. South America Oral Solid Dosage Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)
Table 112. South America Oral Solid Dosage Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)
Table 113. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 114. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 116. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)
Table 118. Middle East & Africa Oral Solid Dosage Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Oral Solid Dosage Contract Manufacturing Picture
Figure 2. Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Type in 2020
Figure 3. Tablets
Figure 4. Capsules
Figure 5. Powders & Granules
Figure 6. Others
Figure 7. Oral Solid Dosage Contract Manufacturing Revenue Market Share by Application in 2020
Figure 8. Specialty/Midsize Picture
Figure 9. Generics Picture
Figure 10. Big Pharma Picture
Figure 11. Other Picture
Figure 12. Global Oral Solid Dosage Contract Manufacturing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Oral Solid Dosage Contract Manufacturing Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Region (2016-2026)
Figure 15. Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Region in 2020
Figure 16. North America Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Oral Solid Dosage Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Oral Solid Dosage Contract Manufacturing Market Drivers
Figure 21. Oral Solid Dosage Contract Manufacturing Market Restraints
Figure 22. Oral Solid Dosage Contract Manufacturing Market Trends
Figure 23. Catalent Recent Developments and Future Plans
Figure 24. DPx Recent Developments and Future Plans
Figure 25. Lonza Group (Capsugel) Recent Developments and Future Plans
Figure 26. Piramal Pharma Solutions Recent Developments and Future Plans
Figure 27. Aenova Recent Developments and Future Plans
Figure 28. Jubilant Recent Developments and Future Plans
Figure 29. Famar Recent Developments and Future Plans
Figure 30. Boehringer Ingelheim Recent Developments and Future Plans
Figure 31. Fareva Holding Recent Developments and Future Plans
Figure 32. AbbVie Contract Manufacturing Recent Developments and Future Plans
Figure 33. Nipro Pharma Recent Developments and Future Plans
Figure 34. Sopharma Recent Developments and Future Plans
Figure 35. Mylan (DPT Laboratories) Recent Developments and Future Plans
Figure 36. Recipharm Recent Developments and Future Plans
Figure 37. NextPharma Recent Developments and Future Plans
Figure 38. Dishman Recent Developments and Future Plans
Figure 39. Aesica Pharmaceuticals Recent Developments and Future Plans
Figure 40. CordenPharma Recent Developments and Future Plans
Figure 42. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Players in 2020
Figure 43. Oral Solid Dosage Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 44. Global Top 3 Players Oral Solid Dosage Contract Manufacturing Revenue Market Share in 2020
Figure 45. Global Top 10 Players Oral Solid Dosage Contract Manufacturing Revenue Market Share in 2020
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 47. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Type in 2020
Figure 48. Global Oral Solid Dosage Contract Manufacturing Market Share Forecast by Type (2021-2026)
Figure 49. Global Oral Solid Dosage Contract Manufacturing Revenue Share by Application in 2020
Figure 50. Global Oral Solid Dosage Contract Manufacturing Market Share Forecast by Application (2021-2026)
Figure 51. North America Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 52. North America Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 53. North America Oral Solid Dosage Contract Manufacturing Revenue Market Share by Country (2016-2026)
Figure 54. United States Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Canada Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Mexico Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Europe Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 58. Europe Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 59. Europe Oral Solid Dosage Contract Manufacturing Revenue Market Share by Country (2016-2026)
Figure 60. Germany Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. France Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. United Kingdom Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Russia Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Italy Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Asia-Pacific Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 66. Asia-Pacific Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue Market Share by Region (2016-2026)
Figure 68. China Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Japan Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South Korea Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. India Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Southeast Asia Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Australia Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South America Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 75. South America Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 76. South America Oral Solid Dosage Contract Manufacturing Revenue Market Share by Country (2016-2026)
Figure 77. Brazil Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Argentina Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Middle East and Africa Oral Solid Dosage Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 80. Middle East and Africa Oral Solid Dosage Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 81. Middle East and Africa Oral Solid Dosage Contract Manufacturing Revenue Market Share by Country (2016-2026)
Figure 82. Turkey Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Saudi Arabia Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. UAE Oral Solid Dosage Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source